A retrospective, population-based matched cohort study was conducted to assess the impact of bariatric surgery on mortality among patients with type 2 diabetes and severe obesity.
Investigators examined the effects of bariatric surgery on cancer risk in patients with NAFLD and severe obesity.
The goal of this study was to determine the safety and efficacy of transcatheter bariatric embolotherapy for weight reduction.
This study examines the clinical characteristics that predict durable long-term diabetes remission after bariatric surgery.
Revisional bariatric surgery in patients with persistent metabolic disease may improve obesity-related comorbidities and metabolic outcomes.
While obesity remains a major concern in the United States of America, both surgical and pharmaceutical interventions have been underutilized, according to results intended to be presented at Digestive Disease Week 2020.
Phentermine and topiramate may aid in the efforts to reduce the occurrence of rapid weight regain after Roux-en-Y gastric bypass surgery.
Researchers compared glycemic control in cohorts of severely obese adolescents with type 2 diabetes undergoing medical and surgical interventions.
Results comparing the prevalence of obesity amongst adolescents with the rate of bariatric surgeries were presented at ENDO 2018.
Roux-en Y gastric bypass increased the likelihood of nonvertebral fractures, including hip, wrist, and pelvic fractures.
